Longo, Dan L.
Harvard Medical School,
United States
2025 Rank: 40658
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 782 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40658 | 44944 |
| Total Cites | 1420 | 1513 |
| H-index | 18 | 19 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 53 | 53 |
| Total Cites to Single Authored Papers | 14 | 14 |
| Number of Single+First Authored Papers | 110 | 110 |
| Total Cites to Single+First Authored Papers | 56 | 56 |
| Number of Single+First+Last Authored Papers | 375 | 375 |
| Total Cites to Single+First+Last Authored Papers | 363 | 367 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1322 | 1387 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.09 |
| Self-Citation Percentage |
6.15%
|
|
Longo, Dan L.
Harvard Medical School,
United States
2024 Rank: 19954
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 421 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19954 | 22118 |
| Total Cites | 1727 | 1813 |
| H-index | 21 | 22 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 54 | 54 |
| Total Cites to Single Authored Papers | 22 | 22 |
| Number of Single+First Authored Papers | 113 | 113 |
| Total Cites to Single+First Authored Papers | 66 | 67 |
| Number of Single+First+Last Authored Papers | 389 | 389 |
| Total Cites to Single+First+Last Authored Papers | 526 | 530 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1642 | 1710 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.06 |
| Self-Citation Percentage |
4.74%
|
|
Longo, Dan L.
Harvard Medical School,
United States
2023 Rank: 25047
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 584 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25047 | 26239 |
| Total Cites | 1673 | 1821 |
| H-index | 19 | 21 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 54 | 54 |
| Total Cites to Single Authored Papers | 30 | 30 |
| Number of Single+First Authored Papers | 112 | 112 |
| Total Cites to Single+First Authored Papers | 66 | 66 |
| Number of Single+First+Last Authored Papers | 376 | 376 |
| Total Cites to Single+First+Last Authored Papers | 443 | 446 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1551 | 1655 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.10 |
| Self-Citation Percentage |
8.13%
|
|
Longo, Dan L.
University of Nebraska Medical Center,
United States
2022 Rank: 18294
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 507 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18294 | 19825 |
| Total Cites | 1830 | 1974 |
| H-index | 20 | 22 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 54 | 54 |
| Total Cites to Single Authored Papers | 33 | 33 |
| Number of Single+First Authored Papers | 111 | 111 |
| Total Cites to Single+First Authored Papers | 75 | 75 |
| Number of Single+First+Last Authored Papers | 374 | 374 |
| Total Cites to Single+First+Last Authored Papers | 462 | 464 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1694 | 1811 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.09 |
| Self-Citation Percentage |
7.29%
|
|
Longo, Dan L.
Harvard Medical School,
United States
2021 Rank: 16074
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 409 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 16074 | 17312 |
| Total Cites | 2755 | 3019 |
| H-index | 24 | 26 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 53 | 53 |
| Total Cites to Single Authored Papers | 52 | 52 |
| Number of Single+First Authored Papers | 110 | 110 |
| Total Cites to Single+First Authored Papers | 142 | 142 |
| Number of Single+First+Last Authored Papers | 372 | 372 |
| Total Cites to Single+First+Last Authored Papers | 742 | 750 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2557 | 2749 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.10 |
| Self-Citation Percentage |
8.74%
|
|
Longo, Dan L.
Harvard Medical School,
United States
2020 Rank: 13227
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 313 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 13227 | 14421 |
| Total Cites | 2014 | 2277 |
| H-index | 22 | 23 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 53 | 53 |
| Total Cites to Single Authored Papers | 41 | 41 |
| Number of Single+First Authored Papers | 111 | 111 |
| Total Cites to Single+First Authored Papers | 127 | 128 |
| Number of Single+First+Last Authored Papers | 374 | 374 |
| Total Cites to Single+First+Last Authored Papers | 592 | 598 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1888 | 2077 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.10 |
| Self-Citation Percentage |
11.55%
|
|